Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Stanke-Labesque F et al. |
2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. |
2004 |
Cardiovasc. Res. |
pmid:15194472
|
Nithipatikom K et al. |
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. |
2004 |
Cancer Res. |
pmid:15604240
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Valenti M et al. |
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. |
2004 |
Cell. Mol. Life Sci. |
pmid:15095014
|
Kishimoto S et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. |
2004 |
J. Biochem. |
pmid:15115777
|
Hájos N et al. |
Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. |
2004 |
Eur. J. Neurosci. |
pmid:15182306
|
Vannacci A et al. |
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15187170
|
Maestroni GJ |
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. |
2004 |
FASEB J. |
pmid:15385435
|
Walter L et al. |
ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. |
2004 |
J. Neurosci. |
pmid:15371507
|
Dinh TP et al. |
RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. |
2004 |
Mol. Pharmacol. |
pmid:15272052
|
Malorni W et al. |
Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets. |
2004 |
Thromb. Haemost. |
pmid:15543349
|
Melis M et al. |
Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. |
2004 |
J. Neurosci. |
pmid:15564588
|
Sugiura T et al. |
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. |
2004 |
J. Pharmacol. Sci. |
pmid:15599096
|
Saario SM et al. |
Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. |
2004 |
Biochem. Pharmacol. |
pmid:15013854
|
Alberich Jordà M et al. |
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. |
2004 |
Blood |
pmid:15039279
|
Witting A et al. |
P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14976257
|
Carrier EJ et al. |
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. |
2004 |
Mol. Pharmacol. |
pmid:15044630
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Motobe T et al. |
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. |
2004 |
Shock |
pmid:14676677
|